Multimedia

On October 29, 2024, the Centers for Disease Control and Prevention (CDC)’s Advisory Committee on Immunization Practices (ACIP) made some recommendations that are going to change the way immunization schedules look for 2025, particularly as they relate to pneumococcal disease and COVID-19 Watch Now ›

Dr Rugo of the University of California San Francisco Comprehensive Cancer Center reports on the outcomes of a retrospective study of patients with metastatic breast cancer and brain metastases treated with abemaciclib. Watch Now ›

Dr Tolaney of Dana-Farber Cancer Institute reviews data on HER2CLIMB-02 and contributes future considerations of tucatinib in the metastatic HER2-positive breast cancer setting. Watch Now ›

Dr Rugo of the University of California San Francisco Comprehensive Cancer Center provides her insights on the practical aspects of the reported results of the INAVO120 phase 3 study. Watch Now ›

Dr Tolaney of Dana-Farber Cancer Institute discusses her perspectives on the clinically meaningful overall survival outcomes of abemaciclib added to a nonsteroidal aromatase inhibitor as initial therapy in patients with HR+/HER2- advanced breast cancer. Watch Now ›